Indegene Limited

New PositionBlock Deal

INDGNHealthcare Research, Analytics & TechnologyMarket Cap₹14K Cr

Value

₹25.04 Cr

4,77,000

Price

₹525

Goldman Sachs

Foreign Investor

The move

Goldman Sachs bought 477,000 shares of Indegene Limited for ₹25.04 Cr at ₹525.00 apiece in a block deal.

About Indegene Limited

Visit stock

A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.

About Goldman Sachs

Visit investor

US-based global investment bank (USD 1.6 trillion in assets, USD 3 trillion+ in client AUM through Goldman Sachs Asset Management). India FPI activity covers proprietary, market-making, client flows and active asset management mandates in listed Indian equities.

Get the next move the moment it happens.

Follow Goldman Sachs and Indegene Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Indegene Limited shareholders Goldman Sachs's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Indegene Limited

Quant Mutual FundNew position

Quant Mutual Fund bought 9,523,810 shares of Indegene Limited for ₹500.00 Cr at ₹525.00 apiece in a block deal.

6 Aug 2026